Nanoparticles are being increasingly used as drug delivery systems to enhance the delivery
to and uptake by target cells and to reduce off-target toxicity of free drugs. However …

Context In response to growing concerns over rising costs and major variation in quality,
improving value for patients has been proposed as a fundamentally new strategy for how …

As the prevalence of smoking continues to decline, dietary factors are rapidly becoming the
leading preventable cause of disease. Diet and obesity are also leading to a shift in cancer …

Background This study aimed to identify the trends in pharmaceutical expenditure (PE),
share of PE in health expenditure (HE), and trends in expenditure by pharmacological …

BACKGROUND: Return to work (RTW) enhances the general well-being and social
participation of cancer survivors (CSs). OBJECTIVE: To describe the predictive value of work …

Importance With rising expenditures on cancer care outpacing other sectors of the US health
system, national attention has focused on insurer spending, particularly for patients with …

Purpose: Survival improvements in multiple myeloma (MM) over the past fifteen years have
been fueled by the introduction of new therapies and changes in treatment patterns. The …

Over the past decade, the financial burden of cancer care on patients and their families has
garnered increased attention. Many of the potential solutions have focused on system-level …

With tyrosine kinase inhibitor (TKI) therapy, chronic myelogenous leukemia (CML) is now a
chronic disease. CML patients treated with TKIs (n= 1200) were identified from the …

Background Metastasectomy is a useful adjunct in the management of metastatic cancer.
Widespread adoption of novel targeted and immunotherapies has improved the survival …